196 related articles for article (PubMed ID: 28426850)
21. Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials.
Wayant C; Fitzgerald K; Hemmerich C; Geng Y; Freyer D; Roth M
JCO Oncol Pract; 2023 Nov; 19(11):1048-1052. PubMed ID: 37748116
[TBL] [Abstract][Full Text] [Related]
22. Improved nutrition in adolescents and young adults after childhood cancer - INAYA study.
Quidde J; von Grundherr J; Koch B; Bokemeyer C; Escherich G; Valentini L; Buchholz D; Schilling G; Stein A
BMC Cancer; 2016 Nov; 16(1):872. PubMed ID: 27825320
[TBL] [Abstract][Full Text] [Related]
23. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
Unger JM; Beauchemin M; Hershman DL
Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
[TBL] [Abstract][Full Text] [Related]
24. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma.
Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y
J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006
[TBL] [Abstract][Full Text] [Related]
25. Risk of subsequent cancer following a primary CNS tumor.
Strodtbeck K; Sloan A; Rogers L; Fisher PG; Stearns D; Campbell L; Barnholtz-Sloan J
J Neurooncol; 2013 Apr; 112(2):285-95. PubMed ID: 23392847
[TBL] [Abstract][Full Text] [Related]
26. Multiple Myeloma in Adolescent and Young Adults: An ASCO CancerLinQ and SEER Analysis.
Gibson S; Thornton J; Sunderland K; Pham K; DeStefano C
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e335-e340. PubMed ID: 37541820
[TBL] [Abstract][Full Text] [Related]
27. Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Rosenberg SM; McCue S; He J; Lafky JM; Carey LA; Galanis E; Leonard JP; Meyerhardt J; Ng K; Schwartz GK; Stock W; Paskett ED; Partridge AH; George S
Cancer; 2024 Mar; 130(5):750-769. PubMed ID: 37916800
[TBL] [Abstract][Full Text] [Related]
28. Characterizing subsequent primary melanomas (SPM) in adolescents and young adults: A population-based study from 1973 to 2011.
Fu T; Swetter SM; Tao L; Geller AC; Clarke CA; Keegan TH
J Am Acad Dermatol; 2016 Jan; 74(1):181-182.e3. PubMed ID: 26702802
[No Abstract] [Full Text] [Related]
29. Prognosis of Second Primary Malignancies in Pediatric Acute Lymphoblastic Leukemia Survivors: A Multicenter Study by the Turkish Pediatric Hematology Society.
Toret E; Aytac S; Guzelkucuk Z; Celkan T; Genc DB; Sezgin-Evim M; Cakmakli HF; Bahadir A; Karapinar TH; Oren H; Pekpak E; Karakurt N; Korkmaz-Unlu HE; Yarali N; Gunes AM
J Pediatr Hematol Oncol; 2024 May; ():. PubMed ID: 38748607
[TBL] [Abstract][Full Text] [Related]
30. Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study.
Harlan LC; Lynch CF; Keegan TH; Hamilton AS; Wu XC; Kato I; West MM; Cress RD; Schwartz SM; Smith AW; Deapen D; Stringer SM; Potosky AL;
J Cancer Surviv; 2011 Sep; 5(3):305-14. PubMed ID: 21274648
[TBL] [Abstract][Full Text] [Related]
31. Survival of Adolescents and Young Adults with Prevalent Poor-Prognosis Metastatic Cancers: A Population-Based Study of Contemporary Patterns and Their Implications.
Sheth Bhutada JK; Hwang AE; Liu L; Tsai KY; Deapen D; Freyer DR
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):900-908. PubMed ID: 35086824
[TBL] [Abstract][Full Text] [Related]
32. The challenge of survivors of gynecological carcinomas: a retrospective study on occurrence of second tumors.
Guo J; Wang H; Zou X; Huang R; Liang Z; Liang S
Arch Gynecol Obstet; 2024 Jul; 310(1):525-533. PubMed ID: 38709268
[TBL] [Abstract][Full Text] [Related]
33. Patient-Reported Outcomes of Accelerated Aging: A Novel Approach to Investigate Second Cancer Risk in Adolescent and Young Adult (18-39 Years) Cancer Survivors.
van der Meer DJ; Zevenbergen S; Vlooswijk C; Bijlsma RM; Kaal SEJ; Kerst JM; Tromp JM; Bos MEMM; van der Hulle T; Lalisang RI; Nuver J; Kouwenhoven MCM; van der Graaf WTA; Husson O
Oncologist; 2024 Apr; 29(4):e526-e534. PubMed ID: 37995309
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and risk factors of bloodstream infections among adolescents and young adults with acute lymphoblastic leukaemia: An 11-year retrospective cohort study.
Xue L; Tang Y; Wang L; Xu C; Cheng Q; Li X
Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13850. PubMed ID: 38452755
[TBL] [Abstract][Full Text] [Related]
35. Association between diabetes and subsequent malignancy risk among older breast cancer survivors.
Hardell KNL; Schonfeld SJ; Ramin C; Vo JB; Morton LM
JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38718185
[TBL] [Abstract][Full Text] [Related]
36. Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type.
Wojcik KY; Hawkins M; Anderson-Mellies A; Hall E; Wysong A; Milam J; Hamilton AS; Cockburn MG
J Am Acad Dermatol; 2023 Apr; 88(4):831-840. PubMed ID: 36610687
[TBL] [Abstract][Full Text] [Related]
37. Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.
Muffly L; Alvarez E; Lichtensztajn D; Abrahão R; Gomez SL; Keegan T
Blood Adv; 2018 Apr; 2(8):895-903. PubMed ID: 29669756
[TBL] [Abstract][Full Text] [Related]
38. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
39. Localized Synovial Sarcoma: A Population-Based Analysis of Treatment Patterns and Survival.
Singh A; Thorpe S; Keegan T; Maguire F; Malogolowkin M; Abrahão R; Spunt S; Carr-Asher J; Alvarez E
J Adolesc Young Adult Oncol; 2023 Oct; 12(5):634-643. PubMed ID: 37104039
[No Abstract] [Full Text] [Related]
40. Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment.
Janardan SK; Miller TP
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):581-586. PubMed ID: 38066874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
